glp-1 agonist cardiovascular outcomes Cardiovascular, mortality, and kidney with receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials GLP-1 receptor agonists and cardiovascular

doi: 10.14814/phy2.14651 [DOI] [PMC free article] [PubMed] [Google Scholar] 27

Over these periods, obesity rates increased substantially among people with type 1 diabetes

SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE

[DOI] [PubMed] [Google Scholar] 898.Pratley R.E., Aroda V.R., Lingvay I., Ludemann J., Andreassen C., Navarria A

Food is Medicine 101 The Food is Medicine 101 continuing education course through University College aims to educate health professionals on the critical link between nutrition and health and its application to the healthcare setting